EarningsQ3 2024 Earnings Report

Nektar Therapeutics (NKTR) Q3 2024 Earnings Report

0 Followers

MX:NKTR Q3 2024 EPS Results

Actual EPS-$48.50

Consensus EPS-$53.62

Beat/MissBeat by +$5.12

One Year Ago EPS-$64.66

Actual Revenue$433.32M

Expected Revenue$344.45M

Beat/MissBeat by +$88.88M

YoY Revenue Growth-0.08%

QuarterQ3 2024

Date11/07/2024

TimeAfter Close

Conference CallThursday, November 7, 2024

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.70 / -	-33.59	―
Aug 13, 2026	2026 (Q2)	-35.40 / -22.09	-52.989	58.31% (+30.90)
May 07, 2026	2026 (Q1)	-28.42 / -32.69	-64.664	49.44% (+31.97)
Mar 12, 2026	2025 (Q4)	-44.44 / -31.97	8.083	-495.56% (-40.06)
Nov 06, 2025	2025 (Q3)	-48.23 / -33.59	-48.498	30.74% (+14.91)
Aug 07, 2025	2025 (Q2)	-54.39 / -52.99	-67.359	21.33% (+14.37)
May 08, 2025	2025 (Q1)	-46.06 / -64.66	-51.193	-26.32% (-13.47)
Mar 12, 2025	2024 (Q4)	-36.54 / 8.08	-59.276	113.64% (+67.36)
Nov 07, 2024	2024 (Q3)	-53.62 / -48.50	-64.664	25.00% (+16.17)
Aug 08, 2024	2024 (Q2)	-49.85 / -67.36	-72.748	7.41% (+5.39)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed